Strategic Risk LLC. 13D/13G Filings for NeuroBo Pharmaceuticals, Inc. (NRBO)

Strategic Risk LLC. 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-03-28
3:30 pm
Purchase
2023-03-2113GNeuroBo Pharmaceuticals, Inc.
NRBO
Strategic Risk LLC.150,354
6.300%
150,354increase
(New Position)
Filing
2023-03-27
4:36 pm
Purchase
2023-03-2113GNeuroBo Pharmaceuticals, Inc.
NRBO
Strategic Risk LLC.150,354
6.300%
150,354increase
(New Position)
Filing